capsaicin has been researched along with dihydroergotamine in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (50.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Boccalini, P; Moskowitz, MA; Nozaki, K | 1 |
| Kumar, KL | 1 |
| Titus, F | 1 |
| Liaño, H; López-Zuazo, I | 1 |
| Markley, HG | 1 |
| Andrews, PL; Cheng, FH; Moreaux, B; Ngan, MP; Rudd, JA; Sam, TS; Wai, MK; Wan, C | 1 |
| Altamirano-Espinoza, AH; González-Hernández, A; MaassenVanDenBrink, A; Manrique-Maldonado, G; Marichal-Cancino, BA; Ruiz-Salinas, II; Villalón, CM | 1 |
4 review(s) available for capsaicin and dihydroergotamine
| Article | Year |
|---|---|
Recent advances in the acute management of migraine and cluster headaches.
Topics: Analgesics; Butorphanol; Capsaicin; Cluster Headache; Dihydroergotamine; Humans; Ketorolac; Metoclopramide; Migraine Disorders; Sumatriptan; Tolmetin | 1994 |
[Symptomatic treatment of cluster headache].
Topics: Alkaloids; Analgesics; Capsaicin; Cluster Headache; Cocaine; Dihydroergotamine; Ergotamine; Humans; Lidocaine; Methoxyflurane; Narcotics; Oxygen; Sumatriptan; Vasoconstrictor Agents | 1995 |
[Prophylactic treatment of episodic forms of cluster headache].
Topics: Adrenal Cortex Hormones; Alkaloids; Calcium Channel Blockers; Capsaicin; Cluster Headache; Dihydroergotamine; Ergotamine; Humans; Lithium; Methysergide; Serotonin Antagonists; Tranquilizing Agents; Vasoconstrictor Agents | 1995 |
Topical agents in the treatment of cluster headache.
Topics: Administration, Intranasal; Administration, Topical; Capsaicin; Cluster Headache; Cocaine; Dihydroergotamine; Humans; Lidocaine; Oxazolidinones; Serotonin Receptor Agonists; Sumatriptan; Tryptamines; Vasoconstrictor Agents | 2003 |
4 other study(ies) available for capsaicin and dihydroergotamine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
CP-93,129, sumatriptan, dihydroergotamine block c-fos expression within rat trigeminal nucleus caudalis caused by chemical stimulation of the meninges.
Topics: Animals; Animals, Newborn; Capsaicin; Carrageenan; Dihydroergotamine; Formaldehyde; Gene Expression Regulation, Neoplastic; Guinea Pigs; Immunohistochemistry; In Vitro Techniques; Indoles; Meninges; Nasal Mucosa; Proto-Oncogene Proteins c-fos; Pyridines; Pyrroles; Rats; Sulfonamides; Sumatriptan | 1992 |
Evaluation of the anti-emetic potential of anti-migraine drugs to prevent resiniferatoxin-induced emesis in Suncus murinus (house musk shrew).
Topics: Animals; Antiemetics; Butanols; Capsaicin; Cyclooxygenase Inhibitors; Dihydroergotamine; Diphenhydramine; Diterpenes; Domperidone; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Humans; Indomethacin; Malates; Methysergide; Metoclopramide; Migraine Disorders; Ondansetron; Piperidines; Ruthenium Red; Scopolamine; Serotonin Antagonists; Serotonin Receptor Agonists; Shrews; Sumatriptan; Time Factors; Tropanes; Vomiting | 2005 |
Intrathecal dihydroergotamine inhibits capsaicin-induced vasodilatation in the canine external carotid circulation via GR127935- and rauwolscine-sensitive receptors.
Topics: Acetylcholine; Animals; Blood Circulation; Calcitonin Gene-Related Peptide; Capsaicin; Carotid Arteries; Dihydroergotamine; Dogs; Dose-Response Relationship, Drug; Hemodynamics; Injections, Spinal; Male; Oxadiazoles; Piperazines; Propylene Glycol; Receptor, Serotonin, 5-HT1B; Serotonin 5-HT1 Receptor Antagonists; Vasodilation; Vasodilator Agents; Yohimbine | 2012 |